Impact of induction regimens intensity and allogeneic stem cell transplantation on survival of patients with Philadelphia chromosome‐positive acute lymphoblastic leukemia: A multi‐institutional study

Documenti analoghi

• Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome‐positive acute lymphoblastic leukemia
  di: Tamer Othman, et al.
  Pubblicazione: (2024)
• Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome‐positive acute lymphoblastic leukemia
  di: Tamer Othman, et al.
  Pubblicazione: (2024)
• Secondary acquisition of the Philadelphia chromosome in acute lymphoblastic leukemia
  di: Qiudan Shen, et al.
  Pubblicazione: (2024)
• Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T‐cell therapy in Philadelphia chromosome‐positive acute lymphoblastic leukaemia
  di: Tamer Othman, et al.
  Pubblicazione: (2024)
• Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real‐world data from eight US academic centers
  di: Yasmin Abaza, et al.
  Pubblicazione: (2024)